Fluid biomarkers in cerebral amyloid angiopathy

Cerebral amyloid angiopathy (CAA) is a type of cerebrovascular disorder characterised by the accumulation of amyloid within the leptomeninges and small/medium-sized cerebral blood vessels. Typically, cerebral haemorrhages are one of the first clinical manifestations of CAA, posing a considerable cha...

Full description

Bibliographic Details
Published in:Frontiers in Neuroscience
Main Authors: Seyed Mehrdad Savar, Bin Ma, Eugene Hone, Farzana Jahan, Shaun Markovic, Steve Pedrini, Soudabeh Shemehsavar, Vandhana Easwaran, Kevin Taddei, Samantha Gardener, Jasmeer P. Chhatwal, Ellis S. van Etten, Matthias J. P. van Osch, Daniel Clarke, Anastazija Gnjec, Mark A. van Buchem, Marieke J. H. Wermer, Graeme J. Hankey, Steven M. Greenberg, Ralph N. Martins, Hamid R. Sohrabi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Subjects:
cerebral amyloid angiopathy
amyloid beta
familial cerebral amyloid angiopathy
differential diagnosis
fluid biomarkers
surrogate endpoints
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2024.1347320/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2024.1347320/full

Similar Items